In addition to the 20-30% of hereditary MTC cases that have germline mutation in the RET proto-oncogene, about 4-10% of patients with sporadic MTC also have germline mutations in the RET protooncogene, that can consequently be inherited in the future. This evidence concerns the gene RET and medullary thyroid gland carcinoma.